Skip to content
Search AI Powered

Latest Stories

In Memoriam: Dr Raphael Mechoulam: 1930 - 2023

In Memoriam: Raphael Mechoulam: 1930-2023
In Memoriam: Raphael Mechoulam: 1930-2023

Raphael Mechoulam, an Israeli chemist who was considered to be the pioneer in the field of cannabis research, passed away on March 6, 2023, at the age of 92.

Born in Bulgaria in 1930, Mechoulam moved to Israel with his family in 1949. He earned a Ph.D. in organic chemistry from the Hebrew University of Jerusalem in 1958 and later became a professor of medicinal chemistry at the same university.


Throughout his career, Mechoulam was known for his groundbreaking work on the chemical compounds of cannabis, which led to the discovery of the plant's psychoactive ingredient, THC, in 1964. He was also the first to isolate cannabidiol (CBD) in 1963, and his research on these compounds' medical benefits has played a significant role in the ongoing legalization and acceptance of medical marijuana.

Raphael Mechoulam's research on cannabis didn't stop with the discovery of THC and CBD. In fact, it was just the beginning. In the 1980s, he turned his attention to understanding how these compounds interact with the human body.

Through his work, Mechoulam discovered the endocannabinoid system (ECS), a complex network of receptors and signaling molecules in the human body that regulate a wide range of physiological processes, including pain sensation, appetite, mood, and inflammation.

The discovery of the ECS was a groundbreaking achievement that opened up new avenues of research and potential therapeutic applications. Mechoulam's research has shown that the human body produces its own cannabinoids, called endocannabinoids, which interact with the ECS in much the same way that THC and CBD do.

Mechoulam's work on the ECS has led to a better understanding of the mechanisms underlying the medical benefits of cannabis, as well as the potential risks and side effects of using the plant for medical purposes.

In recent years, Mechoulam continued to make significant contributions to the field of cannabis research. He was involved in the development of new cannabis-based drugs, such as cannabidiolic acid methyl ester (HU-580), which showed promise in treating inflammatory bowel disease.

His research has also highlighted the potential of cannabis for treating conditions such as post-traumatic stress disorder (PTSD), Alzheimer's disease, and chronic pain.

Raphael Mechoulam's pioneering work on cannabis and the endocannabinoid system has had a profound impact on the field of medical research and has paved the way for new treatments and therapies. His legacy will continue to inspire scientists and researchers for years to come.

Mechoulam’s work on cannabis continued for over five decades, investigating the plant's effects on conditions such as epilepsy, pain, and multiple sclerosis. In 2013, he received the prestigious Rothschild Prize for his contributions to medical research.

Mechoulam's most recent work focused on the potential of cannabis to treat cancer. He collaborated with other researchers on studies that demonstrated cannabis's ability to kill cancer cells in the laboratory, and he advocated for further research on the subject.

In addition to his cannabis research, Mechoulam made significant contributions to the field of chemistry more broadly. He authored over 400 scientific papers and was the recipient of numerous awards and honors.

Mechoulam's legacy is evident in the growing acceptance of medical marijuana around the world, as well as in the expanding body of research on the plant's potential medical benefits. 

He will be remembered as a pioneering scientist whose dedication to understanding the complexities of cannabis helped to unlock its secrets and pave the way for new treatments and therapies.

May his memory be a blessing. 

More For You

map of medical and recreational cannabis retailers in state of New York
NY Cannabis Program Under Fire for Misconduct
NY Cannabis Program Under Fire for Misconduct

Legal Weed, Legit?

New York’s legal cannabis industry was supposed to be the nation’s model of equity and regulation. Instead, it’s quickly becoming a cautionary tale. And the latest news doesn’t just raise eyebrows—it should set off alarms across the entire industry.

According to an April 7 report byThe New York Times, New York State regulators are conducting a sweeping investigation into some of the biggest cannabis companies operating in the state—Stiiizy, Grön, Mfused, and others—over allegations of using out-of-state or unauthorized cannabis to produce products for legal dispensaries. It’s a practice insiders call inversion—and it’s been the industry’s not-so-secret open secret for years.

Keep ReadingShow less
Transparency in NY's Cannabis Market: The NYMCIA Controversy
Transparency in NY's Cannabis Market: The NYMCIA Controversy
Transparency in NY's Cannabis Market: The NYMCIA Controversy

Selective Outrage Hurts NY Cannabis

Authored by: Veterans Holdings CEO Jason Ambrosino

Last week, the New York Medical Cannabis Industry Association (NYMCIA) issued a press release accusing licensed dispensaries of selling "out-of-state cannabis" and undermining the integrity of the legal market. Read the press release here.

Keep ReadingShow less
Ranking Magic Mushrooms by Potency
Ranking Magic Mushrooms by Potency
Tripsitter

Shroom Showdown: Ranking Magic Mushrooms by Potency

From  Psilocybe azurescens to Psilocybe cubensis   — the potency of magic mushrooms varies greatly.

A single gram of one species is enough to shift reality on its axis — the same amount of another may be barely perceptible.

Keep ReadingShow less
Why is Golden Teacher so popular?
Why is Golden Teacher so popular?

Golden Teacher Mushrooms: Everything You Need to Know

Golden Teacher mushrooms (GT Mushrooms) are one of the most popular strains of psilocybin mushrooms. They are mostly cultivated for their above-average psilocybin potency, which serves as a beginner's gateway to psychedelic mushrooms. They feature caramel-colored stems and caps speckled with yellow hence the name Golden Teacher. 

These psychedelic mushroom strains are also known as golden caps, boomers, goldies, caps, and cubies. While the information on their origin is quite unknown or undocumented, anecdotal reference shows that the golden teacher mushrooms were first reported in a scientific literature in 1906 in Cuba, while research on the strains is most likely to have started in the early eighties. 

Keep ReadingShow less
Getting you ready for your first magic mushroom trip - The Bluntness

Getting you ready for your first magic mushroom trip - The Bluntness

How Long Do Shrooms Last? Magic Mushroom Guide for Beginners

In 2022, general interest in magic mushrooms has spiked to unprecedented levels not seen since the 1960s. Thanks to research showing promising results for patients, lawmakers a handful of states and cities already have or are considering loosening psilocybin restrictions.

A few states such as Oregon have fully legalized psilocybin treatment for all adult patients, while others want to limit it to veterans or others with PTSD.

Keep ReadingShow less